Moody's: Envision unchanged on add-on

Moody's Investors Service said it believes Envision Healthcare's $500 million incremental term loan add-on is modestly credit negative because it will temporarily increase the company's financial leverage.

However, the incremental borrowings do not have an impact on Envision's existing ratings, including its B1 corporate family rating or the positive outlook Moody's said.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.